PHRX PHRX

Pharmagen (CE) Stock Price

0.000001
0.00 (0.0%)
0.000001
Volume 0.00
Bid Price
Ask Price
News -
Day High

Low
0.000001

52 Week Range

High
0.0003

Day Low
Company Name Stock Ticker Symbol Market Type
Pharmagen Inc (CE) PHRX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.000001 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.000001 0.000001
Trades Volume Avg Volume 52 Week Range
0 0.00 - 0.000001 - 0.0003
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.000001 USD

Period:

Draw Mode:

Pharmagen Inc (CE) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 517.08 517.08M 145.50M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
14.83k $ - - - -

more financials information »

Pharmagen (CE) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PHRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.0000010.0000010.0000010.00000119,6710.000.0%
1 Month0.0000010.0000010.0000010.00000119,6710.000.0%
3 Months0.0000010.00010.0000010.00000188,0590.000.0%
6 Months0.0000010.00030.0000010.00012568,7420.000.0%
1 Year0.00010.00030.0000010.000096143,824-0.0001-99.0%
3 Years0.00070.00390.0000010.0006358250,971-0.0007-99.86%
5 Years0.0010.00550.0000010.000929258,354-0.001-99.9%

Pharmagen (CE) Description

With a multi-faceted approach, Pharmagen, Inc. is meeting the demands of the health provider market through dynamic, independent wholesale, compounding/admix, and innovative IT solutions. Nationally focused, we are a distributor of specialty drugs, compounding and admix pharmacy and producer of over-the-counter ("OTC") branded multivitamins to the healthcare provider market. The Food and Drug Administration continues to see an increasing number of shortages, especially those involving sterile injectable drugs. We currently function as a total solution provider to hospitals through sterile compounding/admix pharmacy and just-in-time source of supply of products that are hard-to-find due to drug manufacturers production shortages. Leveraging our understanding of drug shortages, our long term goal is to become an FDA approved manufacturer of habitually short supply, sterile pharmaceuticals. Through an industry changing, cGMP + process, utilizing single-use, modular systems, we intend to be the gold standard of sterile production in the United States. In addition to pharmaceuticals, we manufacture and distribute over-the-counter ("OTC") branded health supplements. Our innovative approach to OTC is to create suites of products that are designed to work in conjunction with prescription medications to alleviate side effects and/or prevent drug interactions. With an aging population, more Americans than ever are on prescription medications and dangerous drug interactions are a growing problem. We are currently analyzing several OTC products that would allow us to become a powerful OTC player in the multi-billon dollar health supplement market.


Your Recent History
USOTC
PHRX
Pharmagen ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now